Main > ENDOCRINOLOGY > Diabetes Type II > Treatment > Co: FR. S. Lixisenatide+Insulin>

---

Co: FR. S. Lixisenatide+Insulin>'s subsections
(*) CA Approval Date: 2020. 12.18
(*) EU Approval Date: 2017. 01.17.
(*) USA Approval Date: 2016. 11.21
+Glargine
Company
Licensor:
RTM (USA)
RTM (USA) Web-Site
USA Patent Numbers

Co: FR. S. Lixisenatide+Insulin>'s products
This section has no products